- All sections
- C - Chemistry; metallurgy
- C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganisms; compositions or test papers therefor; processes of preparing such compositions; condition-responsive control in microbiological or enzymological processes
- C12Q 1/6848 - Nucleic acid amplification reactions characterised by the means for preventing contamination or increasing the specificity or sensitivity of an amplification reaction
Patent holdings for IPC class C12Q 1/6848
Total number of patents in this class: 775
10-year publication summary
|
13
|
33
|
45
|
81
|
120
|
89
|
118
|
132
|
72
|
34
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Natera, Inc. | 265 |
39 |
| Bio-Rad Laboratories, Inc. | 1592 |
27 |
| Life Technologies Corporation | 3068 |
20 |
| Gen-Probe Incorporated | 954 |
18 |
| Illumina, Inc. | 2771 |
17 |
| President and Fellows of Harvard College | 5792 |
12 |
| F. Hoffmann-La Roche AG | 7958 |
10 |
| Roche Molecular Systems, Inc. | 878 |
10 |
| Illumina Cambridge Limited | 678 |
9 |
| Roche Sequencing Solutions, Inc. | 565 |
9 |
| Qiagen GmbH | 913 |
8 |
| Qiagen Sciences, LLC | 179 |
8 |
| Integrated DNA Technologies, Inc. | 266 |
7 |
| Lumiradx UK Ltd | 56 |
7 |
| Samplix ApS | 29 |
7 |
| Roche Diagnostics GmbH | 2745 |
6 |
| Purdue Research Foundation | 3277 |
6 |
| New England BioLabs, Inc. | 460 |
6 |
| Pacific Biosciences of California, Inc. | 738 |
6 |
| Raytheon BBN Technologies Corp. | 407 |
6 |
| Other owners | 537 |